Search results for "ASIS"

showing 10 items of 4190 documents

Dogs and Guinea worm eradication

2016

After 30 years of control campaigns, guinea worm faces eradication. However, dogs are expected to thwart the eradication of dracunculiasis as they act as alternative hosts of the worm. The health community un doubtedly have to recognise the success of the Guinea Worm Eradication Program (GWEP), although some flaws cannot be overlooked. One of the most essential points when trying to achieve the control of parasitic infections is to determine the role of reservoirs that could maintain the disease. Erroneously, dogs are likely to have been ignored as reservoirs of Dracunculus medinensis so far. I fi nd it hard to believe that a parasite that has always been considered specific to humans is ab…

0301 basic medicineDisease reservoir030231 tropical medicineZoologyIncubation period03 medical and health sciencesDogs0302 clinical medicineParatenicparasitic diseasesmedicineAnimalsHumansDisease EradicationLarvicideDisease ReservoirsDracunculiasisbiologyDisease EradicationDracunculiasisDracunculus Nematodebiology.organism_classificationmedicine.diseaseDracunculus (nematode)030104 developmental biologyInfectious DiseasesDracunculus medinensisThe Lancet Infectious Diseases
researchProduct

The Guinea Worm: A Zoonotic Parasite of Dogs

2017

0301 basic medicineDracunculiasisDracunculiasis030231 tropical medicineZoologyDracunculus NematodeBiologymedicine.disease03 medical and health sciencesDracunculus NematodeDogs030104 developmental biology0302 clinical medicineInfectious DiseasesZoonosesAfricamedicineAnimalsHumansParasite hostingParasitologyTrends in Parasitology
researchProduct

Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems

2018

Despite growing research, drug-induced liver injury (DILI) remains a serious issue of increasing importance to the medical community that challenges health systems, pharmaceutical industries and drug regulatory agencies. Drug-induced cholestasis (DIC) represents a frequent manifestation of DILI in humans, which is characterised by an impaired canalicular bile flow resulting in a detrimental accumulation of bile constituents in blood and tissues. From a clinical point of view, cholestatic DILI generates a wide spectrum of presentations and can be a diagnostic challenge. The drug classes mostly associated with DIC are anti-infectious, anti-diabetic, anti-inflammatory, psychotropic and cardiov…

0301 basic medicineDrugmedicine.drug_classmedia_common.quotation_subjectReceptors Cytoplasmic and NuclearMiscellaneous DrugsIn Vitro TechniquesToxicologyBioinformaticsBile flow03 medical and health sciences0302 clinical medicineCholestasismedicineAnimalsBileHumansDrug induced cholestasismedia_commonCholestasisPolymorphism GeneticBile acidbusiness.industryMembrane Transport ProteinsGeneral Medicinemedicine.diseaseGastrointestinal MicrobiomeMicroRNAs030104 developmental biologyCardiovascular agent030211 gastroenterology & hepatologyChemical and Drug Induced Liver InjurybusinessFood ScienceHealthcare systemFood and Chemical Toxicology
researchProduct

A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC …

2019

Drug-induced liver injury (DILI) is a matter of concern in the course of drug development and patient safety, often leading to discontinuation of drug-development programs or early withdrawal of drugs from market. Hepatocellular toxicity or impairment of bile acid (BA) metabolism, known as cholestasis, are the two clinical forms of DILI. Whole-body physiology-based modelling allows a mechanistic investigation of the physiological processes leading to cholestasis in man. Objectives of the present study were: (1) the development of a physiology-based model of the human BA metabolism, (2) population-based model validation and characterisation, and (3) the prediction and quantification of alter…

0301 basic medicineEXPRESSIONPBPKLIVERmedicine.drug_classPhysiologyBenign Recurrent Intrahepatic CholestasisPopulationBIOMARKERScomputational modellingPhysiologyDIAGNOSISlcsh:Physiology03 medical and health scienceschemistry.chemical_compoundPHARMACOKINETIC MODEL0302 clinical medicineCholestasisPhysiology (medical)Glycochenodeoxycholic acidMedicineddc:610educationEnterohepatic circulationKINETICSOriginal ResearchLiver injuryINTRAHEPATIC CHOLESTASISbile acidseducation.field_of_studyBile acidlcsh:QP1-981business.industryBRIC type 2medicine.diseaseTRANSPORTERS3. Good health030104 developmental biologychemistryToxicitySIMULATION030211 gastroenterology & hepatologyENTEROHEPATIC CIRCULATIONDILIbusinesscholestasisFrontiers in Physiology
researchProduct

Partial resistance to homologous challenge infections of the digenean Echinostoma caproni in ICR mice

2015

AbstractIn the present paper, we analyse the effect of a primary infection of ICR mice with Echinostoma caproni (Trematoda: Echinostomatidae) on the generation of resistance against homologous challenge infections. In ICR mice, E. caproni induces chronic infections concomitantly with strong responses characterized by the development of T-helper 1 (Th1)-type local immune responses with elevated levels of local interferon-gamma (IFN-γ) and inflammatory and antibody responses. Here, the effect of the response generated against a primary infection with E. caproni in the generation of resistance against subsequent homologous infections was analysed. For this purpose, ICR mice were challenged wit…

0301 basic medicineEchinostoma caproniAntibodies HelminthMicrobiologyInterferon-gamma03 medical and health sciencesImmune systemEchinostomaHomologous chromosomeAnimalsParasite hostingDisease ResistanceInflammationEchinostomiasisMice Inbred ICRbiologyGeneral MedicineTh1 Cellsbiology.organism_classificationDisease Models Animal030104 developmental biologyAntibody responseAnimal Science and ZoologyParasitologyTrematodaIcr miceJournal of Helminthology
researchProduct

Exosomes in cancer theranostic: Diamonds in the rough

2017

IF 3.306; International audience; During the last 10 years, exosomes, which are small vesicles of 50-200 nm diameter of endosomal origin, have aroused a great interest in the scientific and clinical community for their roles in intercellular communication in almost all physiological and pathological processes. Most cells can potentially release these nanovesicles that share with the parent cell a similar lipid bilayer with transmembrane proteins and a panel of enclosed soluble proteins such as heat shock proteins and genetic material, thus acting as potential nanoshuttles of biomarkers. Exosomes surface proteins allow their targeting and capture by recipient cells, while the exosomes' conte…

0301 basic medicineEndosomeReviewexosomes[SDV.BC]Life Sciences [q-bio]/Cellular BiologyBiologyModels BiologicalTheranostic NanomedicineMetastasis03 medical and health sciencesCellular and Molecular NeuroscienceDrug Delivery SystemsNeoplasmsHeat shock proteincancer diagnosisBiomarkers TumormedicineAnimalsHumansTumor microenvironment[ SDV.BC ] Life Sciences [q-bio]/Cellular BiologyCancerCell Biologymedicine.diseasePrimary tumorMicrovesicles3. Good healthCell biology030104 developmental biologyTumor progressionheat shock proteinscancer therapy
researchProduct

The Transcription Factor MAZR/PATZ1 Regulates the Development of FOXP3+ Regulatory T Cells

2019

Summary: Forkhead box protein P3+ (FOXP3+) regulatory T cells (Treg cells) play a key role in maintaining tolerance and immune homeostasis. Here, we report that a T cell-specific deletion of the transcription factor MAZR (also known as PATZ1) leads to an increased frequency of Treg cells, while enforced MAZR expression impairs Treg cell differentiation. Further, MAZR expression levels are progressively downregulated during thymic Treg cell development and during in-vitro-induced human Treg cell differentiation, suggesting that MAZR protein levels are critical for controlling Treg cell development. However, MAZR-deficient Treg cells show only minor transcriptional changes ex vivo, indicating…

0301 basic medicineFOXP3PATZ1chemical and pharmacologic phenomenaBiologyTreg cellGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineIntestinal inflammationmedicineForkhead Box Protein P3Immune homeostasisColitisTranscription factorlcsh:QH301-705.5DSS-induced colitisMAZRT(reg)FOXP3hemic and immune systemsmedicine.diseaseCell biology030104 developmental biologyregulatory T cellslcsh:Biology (General)030217 neurology & neurosurgeryCell Reports
researchProduct

Higher physiopathogenicity byFasciola giganticathan by the genetically closeF. hepatica: experimental long-term follow-up of biochemical markers

2016

Background: Fascioliasis is caused by Fasciola hepatica and F. gigantica. The latter, always considered secondary in human infection, nowadays appears increasingly involved in Africa and Asia. Unfortunately, little is known about its pathogenicity, mainly due to difficulties in assessing the moment a patient first becomes infected and the differential diagnosis with F. hepatica. Methods: A long-term, 24-week, experimental study comparing F. hepatica and F. giganticawas made for the first time in the same animal model host, Guirra sheep. Serum biochemical parameters of liver damage, serum electrolytes, protein metabolism, plasma proteins, carbohydrate metabolism, hepatic lipid metabolism and…

0301 basic medicineFascioliasisMitochondrial DNAFasciola gigantica030231 tropical medicineAntibodies HelminthProtein metabolismSheep DiseasesPhysiologyCarbohydrate metabolismDiagnosis Differential03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSpecies SpecificityHepaticaparasitic diseasesAnimalsFasciola hepaticaBiochemical markersSheepbiologyPublic Health Environmental and Occupational HealthGeneral MedicineDNA Helminth030108 mycology & parasitologybiology.organism_classificationBlood proteinsFasciolaDisease Models AnimalInfectious DiseaseschemistryImmunoglobulin GParasitologyBiomarkersTransactions of The Royal Society of Tropical Medicine and Hygiene
researchProduct

CIAS detection of Fasciola hepatica/F. gigantica intermediate forms in bovines from Bangladesh

2015

Fascioliasis is an important food-borne parasitic zoonosis caused by two trematode species, Fasciola hepatica and Fasciola gigantica. The characterisation and differentiation of Fasciola populations is crucial to control the disease, given the different transmission, epidemiology and pathology characteristics of the two species. Lineal biometric features of adult liver flukes infecting livestock have been studied to characterise and discriminate fasciolids from Bangladesh. An accurate analysis was conducted to phenotypically discriminate between fasciolids from naturally infected bovines (cattle, buffaloes) throughout the country. Morphometric analyses were made with a computer image analys…

0301 basic medicineFascioliasisVeterinary medicineBiometryFasciola gigantica030231 tropical medicineCattle DiseasesCattle Diseases03 medical and health sciences0302 clinical medicineHepaticaparasitic diseasesmedicineAnimalsFasciola hepaticaBangladeshbiologyFasciolabusiness.industryZoonosis030108 mycology & parasitologybiology.organism_classificationmedicine.diseaseFasciolaMalalties parasitàriesParasitologyCattleParasitologyLivestockbusinessBestiar boví
researchProduct

Epidemiology of fascioliasis in human endemic areas

2005

AbstractConsidered a secondary zoonotic disease until the mid-1990s, human fascioliasis is at present emerging or re-emerging in many countries, including increases of prevalence and intensity and geographical expansion. Research in recent years has justified the inclusion of fascioliasis in the list of important human parasitic diseases. At present, fascioliasis is a vector-borne disease presenting the widest known latitudinal, longitudinal and altitudinal distribution.Fasciola hepaticahas succeeded in expanding from its European original geographical area to colonize five continents, despite theoretical restrictions related to its biology and in turn dependent upon environmental and human…

0301 basic medicineFascioliasismedicine.medical_specialtyEndemic DiseasesRange (biology)030231 tropical medicineHelminthiasisDistribution (economics)DiseaseBiologyZoonotic diseaseDisease Outbreaks03 medical and health sciences0302 clinical medicineEnvironmental healthEpidemiologyPrevalencemedicineAnimalsHumansChildbusiness.industryTransmission (medicine)AltitudeGeneral MedicineFasciola hepatica030108 mycology & parasitologymedicine.diseaseFasciolaHuman fascioliasisFemaleAnimal Science and ZoologyParasitologybusinessJournal of Helminthology
researchProduct